Generic name:meningococcal vaccine, tetanus toxoid conjugate quadrivalent (intramuscular route) [ me-NINJ-oh-kok-kal-VAX-een, TET-a-nus-TOX-oyd-KON-joo-gate-kwa-drah-VAY-lent ]
Medically reviewed by Drugs.com. Last updated on Jan 29, 2022.
Commonly used brand name(s)
In the U.S.
- MenQuadfi
Available Dosage Forms:
- Solution
Therapeutic Class: Vaccine
Uses for MenQuadfi
Meningococcal, tetanus toxoid conjugate quadrivalent vaccine is an active immunizing agent used to prevent infection caused by certain groups of meningococcal bacteria (Neisseria meningitides). The vaccine works by causing your body to produce its own protection (antibodies) against the disease.
This vaccine is active against Groups A, C, W, and Y meningococcal bacteria only. The vaccine will not protect against infection caused by other meningococcal bacteria groups, such as Group B.
Meningococcal infection can cause life-threatening illnesses, such as meningococcal meningitis, which affects the brain, and meningococcemia, which affects the blood. Some persons with meningococcal meningitis and/or meningococcemia also may die. These diseases are more likely to occur in young children and in persons with certain diseases or conditions that make them more susceptible to a meningococcal infection or more likely to develop serious problems from a meningococcal infection.
This vaccine is to be given only by or under the supervision of your doctor.
Before using MenQuadfi
In deciding to use a vaccine, the risks of taking the vaccine must be weighed against the good it will do. This is a decision you and your doctor will make. For this vaccine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
